Doxapram for the prevention and treatment of apnea in preterm infants

20222 citationsJournal Articlegreen Open Access

Authors

Shannon Evans · University of Louisville

Marie Berg · Johns Hopkins All Children's Hospital

Matteo Bruschettini · Skåne University Hospital

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the effects of doxapram administration on the incidence of apnea and longer‐term clinical outcomes in preterm infants.

Topics & Keywords

Neonatal Respiratory Health Research Neuroscience of respiration and sleep Infant Development and Preterm Care

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cochrane Database of Systematic Reviews

Volume 2022, Issue 3

DOI: 10.1002/14651858.cd014145

Field-Weighted Citation Impact: 0.30